Interestingly, DC-SIGN expression has been observed in various cancer cells, including NSCLC, colon cancer, and gastric cancer cells [47, 72], and has been associated with enhanced migration and metastatic potential. Here, CD209 is linked to non-small cell lung carcinoma.